SCM
AGN

Soleus Capital Management’s Allergan plc AGN Stock Holding History

Soleus Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,600
Closed -$2.59M – 76
2020
Q1 		$2.59M Sell
14,600
-13,900
-49% -$2.62M 3.01% 12
2019
Q4 		$5.45M Buy
+28,500
New +$5.14M 5.25% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Soleus Capital Management's AGN Position: Q2 2020 in Review

Soleus Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,600 shares — an estimated $2.59M sold.

Soleus Capital Management first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $5.45M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Soleus Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Soleus Capital Management sold 14,600 Allergan plc shares in Q2 2020, an estimated $2.59M.
  • Soleus Capital Management first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Soleus Capital Management's Allergan plc position peaked at $5.45M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Soleus Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.